Literature DB >> 2834454

Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.

W M Kast1, C J Boog, B O Roep, A C Voordouw, C J Melief.   

Abstract

C57BL/6 (B6, H-2b) mice are CTL responders to both Sendai virus and Moloney leukemia virus. In the former response the H-2Kb class I MHC molecule is used as CTL restriction element, in the latter response the H-2Db molecule. B6 dendritic cells (DC) are superior in the presentation of Sendai virus Ag to CTL in comparison with B6 normal spleen cells. Con A blasts have even less capacity to present viral Ag than NSC, and LPS blasts show an intermediate capacity to present viral Ag. H-2Kb mutant bm1 mice do not generate a CTL response to Sendai virus, but respond to Moloney leukemia virus, as demonstrated by undetectable CTL precursors to Sendai virus and a normal CTL precursor frequency to Moloney virus. Compared to B6 mice, other H-2Kb mutant mice show decreased Sendai virus-specific CTL precursor frequencies in a hierarchy reflecting the response in bulk culture. The Sendai virus-specific CTL response defect of bm1 mice was not restored by highly potent Sendai virus-infected DC as APC for in vivo priming and/or in vitro restimulation. In mirror image to H-2Kb mutant bm1 mice, H-2Db mutant bm14 mice do not generate a CTL response to Moloney virus, but respond normally to Sendai virus. This specific CTL response defect was restored by syngeneic Moloney virus-infected DC for in vitro restimulation. This response was Kb restricted indicating that the Dbm14 molecule remained largely defective and that a dormant Kb repertoire was aroused after optimal Ag presentation by DC. In conclusion, DC very effectively present viral Ag to CTL. However, their capacity to restore MHC class I determined specific CTL response defects probably requires at least some ability of a particular MHC class I/virus combination to associate and thus form an immunogenic complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Dendritic cells efficiently induce protective antiviral immunity.

Authors:  B Ludewig; S Ehl; U Karrer; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.

Authors:  F Kievits; J Wijffels; W Lokhorst; P Ivanyi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 3.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Authors:  N Bhardwaj; A Bender; N Gonzalez; L K Bui; M C Garrett; R M Steinman
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

5.  Activity of the adenosine deaminase promoter in transgenic mice.

Authors:  D Valerio; H van der Putten; F M Botteri; P M Hoogerbrugge
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

6.  Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity.

Authors:  M Kruse; O Rosorius; F Krätzer; G Stelz; C Kuhnt; G Schuler; J Hauber; A Steinkasserer
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.

Authors:  S E Macatonia; S Patterson; S C Knight
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

Review 8.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

9.  Dendritic cells efficiently immunoselect mycobacterial-reactive T cells in human blood, including clonable antigen-reactive precursors.

Authors:  P Pancholi; R M Steinman; N Bhardwaj
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

10.  Interaction of human immunodeficiency virus type 1, human T-cell leukemia/lymphoma virus type I (HTLV-I), and HTLV-II with in vitro-generated dendritic cells.

Authors:  D Zucker-Franklin; M Fraig; G Grusky
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.